Leidos · 1 week ago
Reverse/Embedded Engineer
Leidos is an innovation company rapidly addressing the world's most vexing challenges in national security and health. They are seeking Senior Reverse/Embedded Software Engineers to develop offensive cyber foundational tool kits for mission-critical requirements.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Utilize programming techniques to evade host-based or network intrusion detection systems
Develop software to capture, analyze, and interpret raw network traffic
Network socket programming including developing packet-level programs, expert packet-level understanding of IP, TCP, and application-level protocols
Deconstructing a variety of hardware and software, focusing on network devices and technologies, and developing capabilities to utilize the vulnerabilities discovered
Designing capabilities from a set of requirements, and preparing detailed designs
Qualification
Required
Must possess active TS/SCI security clearance to be considered for this role
Bachelor's degree in computer science, Computer Engineering, or similar field of study with a minimum of twelve (12) years of development experience
Expert in software design and development in Python and C/C++
Demonstrated offensive cyber experience programming cyber tools and/or techniques for the U.S. Government or within the commercial sector
Proficiency in network protocols, routers, and network security
Preferred
Experience with firmware and/or embedded systems reverse engineering
Experience programming in Assembly
Experience utilizing reverse engineering tools such as IDA Pro and Ghidra to analyze firmware of embedded devices
Experience with automated testing frameworks
Experience with Docker and container orchestration
Benefits
Paid Time Off
11 paid Holidays
401K with a 6% company match and immediate vesting
Discounted Stock Purchase Plans
Parental Paid Leave
On-site free gym
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase